Thus, due to the absence of hematological alterations and distinct epidemiological profile, the neoplasm is appropriately classified as unclassified renal cell carcinoma (RCC) with medullary phenotype and SMARCB1 deficiency. Here, SMARCB1 is linked to renal cell carcinoma.